Brii Biosciences Future Growth
Future criteria checks 2/6
Brii Biosciences is forecast to grow earnings and revenue by 21.8% and 71.7% per annum respectively. EPS is expected to grow by 25.2% per annum. Return on equity is forecast to be -26.8% in 3 years.
Key information
21.8%
Earnings growth rate
25.2%
EPS growth rate
| Biotechs earnings growth | 40.0% |
| Revenue growth rate | 71.7% |
| Future return on equity | -26.8% |
| Analyst coverage | Low |
| Last updated | 14 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 315 | -792 | N/A | N/A | 1 |
| 12/31/2025 | 207 | -817 | N/A | N/A | 1 |
| 12/31/2024 | 117 | -911 | N/A | N/A | 1 |
| 12/31/2023 | 110 | -717 | N/A | N/A | 1 |
| 6/30/2023 | 134 | -327 | -720 | -581 | N/A |
| 3/31/2023 | 128 | -405 | -678 | -539 | N/A |
| 12/31/2022 | 122 | -484 | -636 | -496 | N/A |
| 9/30/2022 | 99 | -1,021 | -591 | -521 | N/A |
| 6/30/2022 | 75 | -1,558 | -546 | -546 | N/A |
| 3/31/2022 | 84 | -2,861 | -713 | -713 | N/A |
| 12/31/2021 | 93 | -4,164 | -880 | -879 | N/A |
| 9/30/2021 | 100 | -3,999 | -838 | -837 | N/A |
| 6/30/2021 | 107 | -3,835 | -796 | -794 | N/A |
| 3/31/2021 | 94 | -2,512 | -600 | -599 | N/A |
| 12/31/2020 | 82 | -1,190 | -404 | -404 | N/A |
| 12/31/2019 | 20 | -521 | -91 | -67 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2137 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2137 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2137 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2137's revenue (71.7% per year) is forecast to grow faster than the Hong Kong market (8.1% per year).
High Growth Revenue: 2137's revenue (71.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2137 is forecast to be unprofitable in 3 years.